陷“假体检”争议？女子体检10年无异常 却确诊癌症晚期 爱康回应

Core Viewpoint - The controversy surrounding Aikang Guobin's health check services has sparked public concern, particularly regarding the accuracy of cancer risk detection over a decade-long period [2][4]. Group 1: Incident Overview - A lawyer, Zhang Xiaoling, underwent health checks at Aikang Guobin for 10 consecutive years without any cancer warnings, only to be diagnosed with late-stage kidney cancer in 2024 [4]. - Zhang claims that Aikang Guobin failed to inform her of potential cancer risks despite a 2023 report indicating a "calcium spot" on her right kidney [4]. - After switching to a different health check provider, Zhang was diagnosed with kidney cancer, which had already metastasized to her bones by early 2025 [4]. Group 2: Company Response - Aikang Group stated that cancer detection depends on various factors, including the timing of the check, methods used, and the expertise of the medical staff [5]. - The company emphasized that their reports accurately reflect the results of the checks conducted at the time and that they would seek third-party verification if any responsibility is claimed [5]. - Aikang Group noted that Zhang's 2023 report did indicate potential issues, and the growth of her cyst from 2023 to 2024 fell within the range typical for cancer progression [5]. Group 3: Industry Context - Aikang Guobin has faced multiple complaints regarding inaccurate health reports and perceived negligence in their services, with over 1,300 complaints recorded on the Black Cat Complaint platform [6]. - The company was founded in 2004 and went public on NASDAQ in 2014, later privatizing in 2019 [9].